WWW.NYTIMES.COM
Ozempic Makers Stock Plunges 20% After Profit Warning
Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a new chief executive, who highlighted the urgency of the moment.
0 Commenti 0 condivisioni 105 Views 0 Anteprima